1. Home
  2. NTR vs ILMN Comparison

NTR vs ILMN Comparison

Compare NTR & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nutrien Ltd.

NTR

Nutrien Ltd.

HOLD

Current Price

$80.68

Market Cap

35.5B

Sector

Industrials

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$211.06

Market Cap

32.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTR
ILMN
Founded
2017
1998
Country
Canada
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.5B
32.3B
IPO Year
2018
2000

Fundamental Metrics

Financial Performance
Metric
NTR
ILMN
Price
$80.68
$211.06
Analyst Decision
Buy
Hold
Analyst Count
22
17
Target Price
$75.45
$124.24
AVG Volume (30 Days)
2.4M
1.5M
Earning Date
05-06-2026
04-30-2026
Dividend Yield
2.95%
N/A
EPS Growth
N/A
170.87
EPS
N/A
2.22
Revenue
N/A
$4,343,000,000.00
Revenue This Year
$4.03
$6.47
Revenue Next Year
N/A
$5.58
P/E Ratio
$18.99
$98.30
Revenue Growth
N/A
N/A
52 Week Low
$53.03
$88.00
52 Week High
$85.36
$231.81

Technical Indicators

Market Signals
Indicator
NTR
ILMN
Relative Strength Index (RSI) 74.15 54.52
Support Level $68.97 $182.76
Resistance Level $85.36 $231.81
Average True Range (ATR) 2.11 9.45
MACD 0.78 -0.77
Stochastic Oscillator 93.08 51.24

Price Performance

Historical Comparison
NTR
ILMN

About NTR Nutrien Ltd.

Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients—nitrogen, potash, and phosphate—although its main focus is potash, where it is the global leader in installed capacity with a roughly 20% market share. The company is also the largest agricultural retailer in North America and Australia, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: